Monte Rosa Therapeutics Investors

23 investors on Angel Roster list Monte Rosa Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Switzerland.

Investors are matched on the company name in their portfolio, so companies that share the name Monte Rosa Therapeutics can appear together.

Investors listed
23
With verified email
52%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 23 Monte Rosa Therapeutics investors

The most complete profiles first. Showing 23 of 23.

  • Brian AtwoodVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsCybersecurityWomen Founded

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Krishna YeshwantVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    Series BHealth CareTelecommunicationsHospitalsE-commerce

    Portfolio: Pixie, Dialpad, Science 37, Synack and 90 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Ali BehbahaniVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BHealth CareE-commerceWomen FoundedEnterprise Software

    Portfolio: Adaptimmune, Monte Rosa Therapeutics, 858 Therapeutics, GOAT and 5 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Alexander MaywegVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Karim FarisVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareTelecommunicationsE-commerceConsumer Goods

    Portfolio: Pixie, Dialpad, Science 37, Synack and 87 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Carlo Rizzuto

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more

    Contact details available

  • Charles Warden

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more

    Contact details available

  • Ross Jaffe

    Venture Capital, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Beckie Robertson

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Bill Link

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Don Milder

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Paul Grayson

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Monte Rosa Therapeutics investors are on Angel Roster?

Angel Roster lists 23 Monte Rosa Therapeutics investors. 12 of them (52%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (20), Private Equity Firms (13) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Monte Rosa Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (5) and Series B (3).

Where are Monte Rosa Therapeutics investors based?

Most are based in the United States (22) and Switzerland (1).

Which companies have Monte Rosa Therapeutics investors backed?

The most-backed portfolio companies among them are Pipeline Therapeutics (12), Gritstone Oncology (12), Vividion Therapeutics (12), Century Therapeutics (12) and Ventus Therapeutics (11).

How do I contact Monte Rosa Therapeutics investors?

Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.